Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Patients' preferences and economic considerations play an important role in treatment decisions:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Severens, Johan L.
Fautrel, Bruno
Watson, Verity
Boonen, Annelies

January 2017

Objective. To evaluate to what extent rheumatologists consider economic aspects and patients' prefer...

Patients' preferences and economic considerations play an important role in treatment decisions:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Severens, Johan L.
Fautrel, Bruno
Watson, Verity
Boonen, Annelies

January 2017

Objective. To evaluate to what extent rheumatologists consider economic aspects and patients' prefer...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs:a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs:a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs:a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement, and selection of attributes and levels

Mathijssen, E.G.E.
Heuckelum, M. van
Dijk, L. van
Vervloet, M.
Zonnenberg, S.M.
Vriezekolk, J.E.
Bemt, B.J.F van den

January 2018

Objective: To comprehensively describe the identification, refinement, and selection of attributes a...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

Patient Preferences for Biologic Agents in Rheumatoid Arthritis: A Discrete-Choice Experiment

Augustovski, Federico
Beratarrechea, Andrea
Irazola, Vilma
Rubinstein, Fernando
Tesolin, Pablo
Gonzalez, Juan
Lencina, Verónica
Scolnik, Marina
Waimann, Christian
Navarta, David
Citera, Gustavo
Soriano, Enrique R.

April 2013

AbstractObjectivesTo assess patients’ preferences for rheumatoid-arthritis treatments with biologic ...

Patient preferences on rheumatoid arthritis second-line treatment : a discrete choice experiment of Swedish patients

Schölin Bywall, Karin
Kihlbom, Ulrik
Hansson, Mats
Falahee, Marie
Raza, Karim
Baecklund, Eva
Veldwijk, Jorien

January 2020

Background Preference assessments of patients with rheumatoid arthritis can support clinical therape...

A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines

Saman Zartab
Shekoufeh Nikfar
Naeim Karimpour-Fard
Ahmadreza Jamshidi
Vida Varahrami
Ali Homayouni
Abbas Kebriaeezadeh

January 2021

Objective: Rheumatoid arthritis is a chronic disease with various clinical characteristics. The intr...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Patients' preferences and economic considerations play an important role in treatment decisions:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Severens, Johan L.
Fautrel, Bruno
Watson, Verity
Boonen, Annelies

January 2017

Objective. To evaluate to what extent rheumatologists consider economic aspects and patients' prefer...

Patients' preferences and economic considerations play an important role in treatment decisions:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Severens, Johan L.
Fautrel, Bruno
Watson, Verity
Boonen, Annelies

January 2017

Objective. To evaluate to what extent rheumatologists consider economic aspects and patients' prefer...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs:a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs:a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs:a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

A discrete choice experiment on preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: the identification, refinement, and selection of attributes and levels

Mathijssen, E.G.E.
Heuckelum, M. van
Dijk, L. van
Vervloet, M.
Zonnenberg, S.M.
Vriezekolk, J.E.
Bemt, B.J.F van den

January 2018

Objective: To comprehensively describe the identification, refinement, and selection of attributes a...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

van Heuckelum, Milou
Mathijssen, Elke G. E.
Vervloet, Marcia
Boonen, Annelies
Hebing, Renske C. F.
Pasma, Annelieke
Vonkeman, Harald E.
Wenink, Mark H.
van den Bemt, Bart J. F.
van Dijk, Liset

January 2019

Background: Although patients have different treatment preferences, these individual preferences cou...

Patient Preferences for Biologic Agents in Rheumatoid Arthritis: A Discrete-Choice Experiment

Augustovski, Federico
Beratarrechea, Andrea
Irazola, Vilma
Rubinstein, Fernando
Tesolin, Pablo
Gonzalez, Juan
Lencina, Verónica
Scolnik, Marina
Waimann, Christian
Navarta, David
Citera, Gustavo
Soriano, Enrique R.

April 2013

AbstractObjectivesTo assess patients’ preferences for rheumatoid-arthritis treatments with biologic ...

Patient preferences on rheumatoid arthritis second-line treatment : a discrete choice experiment of Swedish patients

Schölin Bywall, Karin
Kihlbom, Ulrik
Hansson, Mats
Falahee, Marie
Raza, Karim
Baecklund, Eva
Veldwijk, Jorien

January 2020

Background Preference assessments of patients with rheumatoid arthritis can support clinical therape...

A Systematic Review of Discrete Choice Experiment Studies in Rheumatoid Arthritis Biological Medicines

Saman Zartab
Shekoufeh Nikfar
Naeim Karimpour-Fard
Ahmadreza Jamshidi
Vida Varahrami
Ali Homayouni
Abbas Kebriaeezadeh

January 2021

Objective: Rheumatoid arthritis is a chronic disease with various clinical characteristics. The intr...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Influence of disease activity on RA treatment choices in countries with restricted access to expensive, innovative drugs: a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Watson, Verity
Berghea, Florian
Péntek, Márta
Keat, Andrew
Severens, Johan L
Fautrel, Bruno
Boonen, Annelies

September 2017

OBJECTIVE: To assess the influence of disease activity of patients with rheumatoid arthritis on trea...

Patients' preferences and economic considerations play an important role in treatment decisions:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Severens, Johan L.
Fautrel, Bruno
Watson, Verity
Boonen, Annelies

January 2017

Objective. To evaluate to what extent rheumatologists consider economic aspects and patients' prefer...

Patients' preferences and economic considerations play an important role in treatment decisions:a discrete choice experiment among rheumatologists

Hifinger, Monika
Hiligsmann, Mickael
Ramiro, Sofia
Severens, Johan L.
Fautrel, Bruno
Watson, Verity
Boonen, Annelies

January 2017

Objective. To evaluate to what extent rheumatologists consider economic aspects and patients' prefer...

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

Abstract

Extracted data

Preferences of patients with rheumatoid arthritis regarding disease-modifying antirheumatic drugs: a discrete choice experiment

Abstract

Extracted data

Related items

Related items